452 related articles for article (PubMed ID: 34182023)
1. Use of drug-eluting stents in patients with critical limb ischemia and infrapopliteal arterial disease: a real-world single-center experience.
AbuRahma AF; Beasley M; Davis M; Adams E; Lee A; Shapiro J; Dean LS; Davis E
J Vasc Surg; 2021 Nov; 74(5):1619-1625. PubMed ID: 34182023
[TBL] [Abstract][Full Text] [Related]
2. Everolimus-Eluting Stent for Patients With Critical Limb Ischemia and Infrapopliteal Arterial Occlusive Disease.
Giaquinta A; Vincenzo A; De Marco E; Veroux M; Veroux P
Vasc Endovascular Surg; 2017 Feb; 51(2):60-66. PubMed ID: 28100126
[TBL] [Abstract][Full Text] [Related]
3. Endovascular Revascularization Incorporating Infrapopliteal Coronary Drug-Eluting Stents Improves Clinical Outcomes in Patients with Critical Limb Ischemia and Tissue Loss.
Huntress LA; Fereydooni A; Dardik A; Nassiri N
Ann Vasc Surg; 2020 Feb; 63():234-240. PubMed ID: 31563654
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Follow-up of the PADI Trial: Percutaneous Transluminal Angioplasty Versus Drug-Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia.
Spreen MI; Martens JM; Knippenberg B; van Dijk LC; de Vries JPM; Vos JA; de Borst GJ; Vonken EPA; Bijlstra OD; Wever JJ; Statius van Eps RG; Mali WPTM; van Overhagen H
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411244
[TBL] [Abstract][Full Text] [Related]
5. One-Year Outcomes of the Paclitaxel-Eluting, Self-Expanding Stentys Stent System in the Treatment of Infrapopliteal Lesions in Patients With Critical Limb Ischemia.
Bosiers M; Callaert J; Keirse K; Hendriks JMH; Peeters P; Verbist J; Maene L; Beelen R; Deloose K
J Endovasc Ther; 2017 Jun; 24(3):311-316. PubMed ID: 28351310
[TBL] [Abstract][Full Text] [Related]
6. Analysis of endovascular therapy for femoropopliteal disease with the Supera stent.
Montero-Baker M; Ziomek GJ; Leon L; Gonzales A; Dieter RS; Gadd CL; Pacanowski JP
J Vasc Surg; 2016 Oct; 64(4):1002-8. PubMed ID: 27444365
[TBL] [Abstract][Full Text] [Related]
7. Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease.
Bosiers M; Scheinert D; Peeters P; Torsello G; Zeller T; Deloose K; Schmidt A; Tessarek J; Vinck E; Schwartz LB
J Vasc Surg; 2012 Feb; 55(2):390-8. PubMed ID: 22169682
[TBL] [Abstract][Full Text] [Related]
8. Amputation-free Survival in Patients with Critical Limb Ischemia Treated with Paclitaxel-eluting Stents and Paclitaxel-coated Balloons.
Phair J; Carnevale M; Lipsitz EC; Shariff S; Scher L; Garg K
Ann Vasc Surg; 2020 Jan; 62():8-14. PubMed ID: 31207400
[TBL] [Abstract][Full Text] [Related]
9. Early and Midterm Experience With the Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold in Asian Patients With Chronic Limb-Threatening Ischemia: One-Year Clinical and Imaging Outcomes From the DISAPEAR Registry.
Kum S; Ipema J; Chun-Yin DH; Lim DM; Tan YK; Varcoe RL; Hazenberg CEVB; Ünlü Ç
J Endovasc Ther; 2020 Aug; 27(4):616-622. PubMed ID: 32469296
[No Abstract] [Full Text] [Related]
10. Midterm Outcomes After Infrapopliteal Interventions in Patients With Critical Limb Ischemia Based on the TASC II Classification of Below-the-Knee Arteries.
Singh GD; Brinza EK; Hildebrand J; Waldo SW; Foley TR; Laird JR; Armstrong EJ
J Endovasc Ther; 2017 Jun; 24(3):321-330. PubMed ID: 28421855
[TBL] [Abstract][Full Text] [Related]
11. Angioplasty versus stenting for infrapopliteal arterial lesions in chronic limb-threatening ischaemia.
Hsu CC; Kwan GN; Singh D; Rophael JA; Anthony C; van Driel ML
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD009195. PubMed ID: 30536919
[TBL] [Abstract][Full Text] [Related]
12. Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease.
Tran K; Ullery BW; Kret MR; Lee JT
Ann Vasc Surg; 2017 Jan; 38():90-98. PubMed ID: 27554688
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes following primary drug-eluting stenting of infrapopliteal bifurcations.
Spiliopoulos S; Fragkos G; Katsanos K; Diamantopoulos A; Karnabatidis D; Siablis D
J Endovasc Ther; 2012 Dec; 19(6):788-96. PubMed ID: 23210878
[TBL] [Abstract][Full Text] [Related]
14. Twelve-Month Results From the MAJESTIC Trial of the Eluvia Paclitaxel-Eluting Stent for Treatment of Obstructive Femoropopliteal Disease.
Müller-Hülsbeck S; Keirse K; Zeller T; Schroë H; Diaz-Cartelle J
J Endovasc Ther; 2016 Oct; 23(5):701-7. PubMed ID: 27193308
[TBL] [Abstract][Full Text] [Related]
15. Primary Self-EXPANDing Nitinol Stenting vs Balloon Angioplasty With Optional Bailout Stenting for the Treatment of Infrapopliteal Artery Disease in Patients With Severe Intermittent Claudication or Critical Limb Ischemia (EXPAND Study).
Schulte KL; Pilger E; Schellong S; Tan KT; Baumann F; Langhoff R; Torsello G; Zeller T; Amendt K; Brodmann M;
J Endovasc Ther; 2015 Oct; 22(5):690-7. PubMed ID: 26245919
[TBL] [Abstract][Full Text] [Related]
16. A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia.
Almasri J; Adusumalli J; Asi N; Lakis S; Alsawas M; Prokop LJ; Bradbury A; Kolh P; Conte MS; Murad MH
J Vasc Surg; 2019 Jun; 69(6S):126S-136S. PubMed ID: 31159976
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and Safety of a Paclitaxel-Eluting Stent for Superficial Femoral Artery Lesions up to 190 mm: One-Year Outcomes of the Single-Arm IMPERIAL Long Lesion Substudy of the Eluvia Drug-Eluting Stent.
Golzar J; Soga Y; Babaev A; Iida O; Kawasaki D; Bachinsky W; Park J; Prem JT; Vermassen F; Diaz-Cartelle J; Müller-Hülsbeck S; Gray WA
J Endovasc Ther; 2020 Apr; 27(2):296-303. PubMed ID: 31989856
[No Abstract] [Full Text] [Related]
18. Outcome of a drug-eluting stent in longer below-the-knee lesions in patients with critical limb ischemia.
Bosiers MJ; Deloose K; Peeters P; Torsello G; Zeller T; Scheinert D; Schmidt A; Maene L; Keirse K; Varcoe R; Bosiers M
J Cardiovasc Surg (Torino); 2017 Feb; 58(1):49-54. PubMed ID: 27455888
[TBL] [Abstract][Full Text] [Related]
19. Single-Center Experience With Lutonix Drug-Coated Balloons in Infrapopliteal Arteries.
Steiner S; Schmidt A; Bausback Y; Bräunlich S; Ulrich M; Banning-Eichenseer U; Scheinert D
J Endovasc Ther; 2016 Jun; 23(3):417-23. PubMed ID: 27099285
[TBL] [Abstract][Full Text] [Related]
20. Three-Year Outcomes of Orbital Atherectomy for the Endovascular Treatment of Infrainguinal Claudication or Chronic Limb-Threatening Ischemia.
Giannopoulos S; Secemsky EA; Mustapha JA; Adams G; Beasley RE; Pliagas G; Armstrong EJ
J Endovasc Ther; 2020 Oct; 27(5):714-725. PubMed ID: 32618486
[No Abstract] [Full Text] [Related]
[Next] [New Search]
